Immunoprecise Antibodies Ltd
XTSX:IPA
Cash Flow Statement
Cash Flow Statement
Immunoprecise Antibodies Ltd
Jan-2022 | ||
---|---|---|
Operating Cash Flow | ||
Net Income |
(19)
|
|
Depreciation & Amortization |
7
|
|
Change in Deffered Taxes |
1
|
|
Other Non-Cash Items |
6
|
|
Cash Taxes Paid |
2
|
|
Cash Interest Paid |
0
|
|
Change in Working Capital |
(2)
|
|
Cash from Operating Activities |
(9)
N/A
|
|
Investing Cash Flow | ||
Capital Expenditures |
(2)
|
|
Other Items |
(1)
|
|
Cash from Investing Activities |
(4)
N/A
|
|
Financing Cash Flow | ||
Net Issuance of Common Stock |
45
|
|
Net Issuance of Debt |
(1)
|
|
Cash from Financing Activities |
43
N/A
|
|
Change in Cash | ||
Effect of Foreign Exchange Rates |
(1)
|
|
Net Change in Cash |
30
N/A
|
|
Free Cash Flow | ||
Free Cash Flow |
(11)
N/A
|